去抗原同种异体大隐静脉移至内瘘的临床应用效果
[Abstract]:Objective to compare the clinical effect of long-term hemodialytic vascular pathway established by antigenic great saphenous vein and artificial blood vessel transplantation materials, and to explore the feasibility, effectiveness and safety of antigen-free great saphenous vein as vascular graft material, and to find an effective vascular graft material for (ESRD) patients with end-stage kidney disease whose vascular depletion can not establish autologous arteriovenous fistula (AVF). Methods A simple random sampling method was used to establish a long-term vascular pathway in the blood purification center of Jinan Central Hospital from May 2015 to December 2016. there were 12 patients in group A and 12 patients in group B (polytetrafluoroethylene, PTFE) group). The patients were followed up for 3 months to 18 months. The symptoms of pain, swelling and numbness, dialysis adequacy (Kt/V), blood flow before complications, puncture hemostasis time, patency rate (3 months, 6 months, 9 months, 12 months, 15 months, 18 months), stenosis, embolism and infection were observed from the following aspects: antigenic great saphenous vein group (group A) and polytetrafluoroethylene transplantation group (group B), such as pain, swelling, numbness and other uncomfortable symptoms, dialysis adequacy (HD), blood flow before complications, puncture hemostasis time, patency rate (3 months, 6 months, 9 months, 12 months, 15 months, 18 months). The incidence of complications such as angiomatoid dilatation, distal limb ischemic sign, swelling hand syndrome and histomorphology (HE staining, expression of CTGF,TGF- 尾 1) after stenosis. EXCEL is used for data input and SPSS19.0 software is used for statistical analysis. The counting data were compared by Fisher test, the measurement data in accordance with normal distribution were expressed by mean 卤standard deviation, and the comparison between groups was carried out by t test, and P 0.05 was statistically significant. Results there was no significant difference in age and primary disease composition between the two groups (P 0.05); A group, 4 patients had postoperative pain and tolerable pain, 1 patient had limb swelling and no limb numbness, 6 patients in group B had postoperative pain, 4 patients had drug analgesia, 4 patients had postoperative limb swelling, 2 patients had mild numbness), 4 patients had postoperative pain, 4 patients had postoperative limb swelling, and 2 patients had mild numbness. During the follow-up period, the Kt/ V values of group A and group B were both 1.4 (P 0.05), A, the blood flow of group B was more than 200ml / min, the blood flow was stable, and there was no insufficient blood flow (P < 0.05). The time of puncture hemostasis at the end of dialysis in group); A was shorter than that in group B (P < 0.05). The patency rate of group A was higher than that of group B at 3 months, 6 months, 9 months, 12 months, 15 months and 18 months after operation. The incidence of infection in group A was lower than that in group B (P 0.01). There was no significant difference in the incidence of stenosis, embolism, angiomatoid dilatation, distal limb ischemia and swollen hand syndrome between the two groups (P 0.05). In group A and group B, the intima were obviously thickened and smooth muscle cells proliferated. CTGF was mainly expressed in intima and adventitia, and TGF- 尾 1 was expressed in intima, media and adventitia, which was brown and yellow in group A and group B. the expression of VEGF 尾 1 in intima, media and adventitia was brown and yellow, and the expression of VEGF 尾 1 in intima, media and adventitia was brown and yellow, respectively. Conclusion 1. The patients with endovascular fistula treated with antigenic great saphenous vein transplantation can achieve sufficient dialysis effect, the blood flow is stable, the hemostatic time is short, the incidence of infection is low 2, resulting in intimal hyperplasia, endothelial cells and smooth muscle fiber cells are the main components of proliferation, especially the proliferation of smooth muscle fibers. 3, when autologous arteriovenous fistula can not be established, Antigenic allogenic great saphenous vein can be used as a good vascular graft material in clinic.
【学位授予单位】:山东大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R459.5
【相似文献】
相关期刊论文 前10条
1 张强,,段志泉;阻抗分析与血管扫描用于诊断移植血管狭窄[J];中国普通外科杂志;1995年04期
2 陈绪军;陈鑫;石开虎;徐明;汪黎明;;冠状动脉旁路移植术后移植血管狭窄的危险因素分析[J];中国胸心血管外科临床杂志;2008年06期
3 李芸;门脉减压——应用H型移植血管的临床经验[J];国外医学参考资料.外科学分册;1975年02期
4 陈燕,张强,段志泉;血管多普勒扫描对移植血管狭窄的诊断价值[J];中国医科大学学报;1998年06期
5 连锋;冠状动脉旁路移植术后移植血管狭窄的治疗研究进展[J];医学综述;1999年10期
6 王敏敏;冠脉旁路移植手术移植血管的选择[J];心血管病学进展;2002年01期
7 马小静 ,任书堂 ,叶蓉 ,胡丽华 ,陶凉 ,尚玉强;多普勒超声在冠状动脉旁路移植术中移植血管检测的初步研究[J];中华超声影像学杂志;2002年11期
8 董士勇;李一帆;宋波;杜迎利;肖锋;李岩;;非体外循环冠状动脉旁路移植术围手术期心肌梗死发生率与移植血管血流量的关系[J];中国胸心血管外科临床杂志;2011年06期
9 张大维;;冠状动脉旁路手术后开始服用阿司匹林对移植血管早期开放的影响[J];国外医学.心血管疾病分册;1992年04期
10 吴忠均,朱毅,时德,郑树森,李德卫;转染血小板源生长因子和增殖细胞核抗原反义寡核苷酸抑制移植血管狭窄的实验研究[J];中华外科杂志;2005年07期
相关会议论文 前2条
1 陈鑫;徐明;邱志兵;蒋英硕;缪劲;郭子璜;肖立琼;;再次冠状动脉旁路移植术12例治疗体会[A];第八届华东六省一市胸心血管外科学术会议论文汇编[C];2005年
2 傅先水;王金锐;唐杰;曹海根;李俊来;罗渝昆;徐建宏;;超声对桡动脉作为移植血管桥的术前筛选和术后评估:附30例患者及150例志愿者尺-桡动脉间侧支循环模式资料[A];中华医学会超声医学新进展学术会议论文汇编[C];2004年
相关重要报纸文章 前3条
1 记者 宜秀萍;省医完成全省首例移植血管瘘成形术[N];甘肃日报;2012年
2 记者 王耀;全省首例移植血管瘘成形术完成[N];甘肃经济日报;2012年
3 记者 刘晓芳;甘肃首例移植血管瘘成形术完成[N];兰州日报;2012年
相关博士学位论文 前2条
1 王齐敏;内皮素受体A反义寡聚核苷酸抑制大鼠移植血管内膜增殖的作用[D];福建医科大学;2004年
2 陆现硕;炎症因子及外膜炎症反应与移植血管动脉硬化早期发病关系的实验研究[D];山东大学;2007年
相关硕士学位论文 前4条
1 白雪;去抗原同种异体大隐静脉移至内瘘的临床应用效果[D];山东大学;2017年
2 成伟;冠状动脉旁路移植术后中远期效果的随访研究及影响因素分析[D];山东大学;2009年
3 高进;利用兔颈动脉旁路移植模型评价新型全生物化小口径移植血管[D];山西医科大学;2011年
4 徐俊文;SM22α和KDR启动子/增强子基因调控PI3K信号通路对移植血管新生内膜增生的影响[D];山西医科大学;2011年
本文编号:2498791
本文链接:https://www.wllwen.com/linchuangyixuelunwen/2498791.html